Skip to content

Can a cannabis-based medicine applied to a non-healing wound improve healing and reduce pain?

Topical cannabis-based medicines for wound healing and pain management

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16488940
Enrollment
30
Registered
2020-03-10
Start date
2018-06-06
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable non-healing wounds afflicting patients with vasculitic and vasculopathic disorders Skin and Connective Tissue Diseases

Interventions

A thin layer of VinSan was applied topically to both the wound bed and peri-wound integumentary tissues (approximately a 2-5 cm cuff around the wound bed) daily until complete wound closure.

Sponsors

William Osler Health System
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Intractable, non-healing integumentary wounds of more than 6 months duration that have failed best practices and evidence-based medical treatments

Exclusion criteria

Exclusion criteria: 1. Declined to sign informed consent 2. Reported a prior misadventure with cannabis 3. Allergy to cannabis

Design outcomes

Primary

MeasureTime frame
Time to complete wound closure as reported by participants or family members

Secondary

MeasureTime frame
1. Wound-related pain assessed in terms of analgesic use in daily milligram morphine equivalents (MME) 2. Wound size (longest length x widest width in cm2) measured at each clinic or home visit by the investigator or their delegate

Countries

Canada

Contacts

Public ContactVincent Maida
vintordoc@icloud.com+1 416-346-6829

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026